Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Citrulline with Simvastatin in PAD
NCT00351286Phase 2Unknown
- Sponsor
- Angiogenix, Inc.
- Start
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral Arterial Disease (PAD) and intermittent claudication (IC) comparing L-citrulline + Simvastatin with Placebo + Simvastatin (2 arms). Primary endpoint: Absolute Claudication Walking Distance at 12 weeks. Status: unknown.
02
Drugs
citrulline
03
Conditions
Peripheral Arterial Disease (PAD)intermittent claudication (IC)
Beyond the preview
Go deeper on NCT00351286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351286.